Oxygen-carbon nanotubes as a chemotherapy sensitizer for paclitaxel in breast cancer treatment.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4121325)

Published in PLoS One on August 04, 2014

Authors

Yongkun Wang1, Chuanying Wang2, Yijun Jia1, Xianhua Cheng2, Qing Lin3, Mingjie Zhu4, Yunshu Lu1, Longlong Ding1, Ziyi Weng5, Kejin Wu1

Author Affiliations

1: Department of General Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
2: School of Mechanical and Power Engineering, Shanghai Jiaotong University, Shanghai, China.
3: Department of Oncology, XinHua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
4: Department of Pathology, XinHua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
5: Department of Anorectal Surgery, XinHua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Articles citing this

Nanotechnology applications in thoracic surgery. Eur J Cardiothorac Surg (2016) 0.77

Articles cited by this

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res (1999) 10.65

Carbon nanotubes--the route toward applications. Science (2002) 10.03

Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci U S A (2005) 7.70

Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev (2007) 6.91

Structure-assigned optical spectra of single-walled carbon nanotubes. Science (2002) 3.80

Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev (2003) 2.25

The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene (2003) 2.22

Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem (2006) 1.83

Scanned probe microscopy of electronic transport in carbon nanotubes. Phys Rev Lett (2000) 1.57

Functionalized carbon nanotubes for potential medicinal applications. Drug Discov Today (2010) 1.39

Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells. Cancer Res (2011) 1.31

Pharmacokinetics, metabolism and toxicity of carbon nanotubes for biomedical purposes. Theranostics (2012) 1.30

Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth. Clin Cancer Res (2006) 1.28

A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomedicine (2011) 1.20

Field emission of individual carbon nanotubes in the scanning electron microscope. Phys Rev Lett (2002) 1.16

Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia. Mol Cancer (2010) 1.12

Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation. J Cell Mol Med (2009) 1.11

Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells. Cancer Res (2011) 1.06

The application of carbon nanotubes in target drug delivery systems for cancer therapies. Nanoscale Res Lett (2011) 1.06

Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res (1995) 1.03

Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells. Mol Pharmacol (2007) 0.99

Restoration of estrogen responsiveness by blocking the HER-2/neu pathway. Oncol Rep (2002) 0.96

Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha. J Cancer Res Clin Oncol (2009) 0.95

Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse. Acta Oncol (1995) 0.93

Immunohistochemical study of VEGF expression in oral squamous cell carcinomas: correlation with the mTOR-HIF-1α pathway. Anticancer Res (2011) 0.90

Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model. Biomaterials (2013) 0.85

Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy. Nanotechnology (2013) 0.85

Carbon nanotubes: applications in pharmacy and medicine. Biomed Res Int (2013) 0.84

Carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors. Anticancer Res (2011) 0.81

Functionalized carbon nanotubes for anticancer drug delivery. Expert Rev Med Devices (2011) 0.81

Beclin1/PI3K-mediated autophagy prevents hypoxia-induced apoptosis in EAhy926 cell line. Cancer Biother Radiopharm (2011) 0.80

Role and mechanism of hypoxia-inducible factor-1 in cell growth and apoptosis of breast cancer cell line MDA-MB-231. Oncol Lett (2010) 0.80

Comparative study of membranotropic action of single- and multi-walled carbon nanotubes. J Biosci Bioeng (2013) 0.77

Carbon nanotubes: a potential concept for drug delivery applications. Recent Pat Drug Deliv Formul (2014) 0.76